Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Percent change in left ventricular volume index (LVVI) at Week 96.
Percent change at Week 96 in left ventricular mass index (LVMI), development of new heart failure, correlation between change in left ventricular indices and average maintenance hemoglobin, 6-minute walking test, and quality of life.
18 Years and older (Adult, Senior)
December 5, 2005
December 3, 2010
† Study has passed its completion date and status has not been verified in more than two years.